No Data
No Data
Jianghai Securities: The new diabetes drug Inzjen has issued the first prescription in the country. It is recommended to pay attention to the Industry Chain related to GLP-1 drugs.
With the continuous strengthening of domestic policies and the proactive response of Chinese Innovative Drugs companies, the ongoing market entry of related Innovative Drugs by Chinese pharmaceutical firms will challenge the global position of Semaglutide products.
Fosun Pharmaceutical Gets US FDA Approval for HLX99 Clinical Trials
Fosun Pharmaceutical Gets Drug Registration for Antibiotic, Hypertension Medications
Hong Kong Stock Announcement | XTEP INT'L plans to issue shares and convertible Bonds to raise 1 billion Hong Kong dollars.
Bank of Qingdao (03866) reported a net profit attributable to shareholders of 4.264 billion yuan for 2024, representing a year-on-year increase of 20.16%.
Fosun Pharma Advances With New Drug Applications
Express News | Shanghai Fosun Pharma - Drug Registration Application of Polymyxin B Sulfate for Injection of Guilin Pharmaceutical Co Accepted by Nmpa